Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Spedali Civili di Brescia Brescia, Italy
  • Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy
  • Ospedale San Carlo Potenza, Italy
  • Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy
View all 17 locations
View Trial Details
Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

NCT00710528

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT01108341

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Hematology Oncology, P.C. Stamford, Connecticut, United States
View all 39 locations
View Trial Details
Completed

Anti-Tac for Treatment of Leukemia

NCT00001941

Conditions
Deltaretrovirus Infections, Diabetes Mellitus, Insulin-Dependent, 10, HTLV-I Infection, +19 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details

Related conditions